Personalized Medicine and Pharmacogenomics

Personalized Medicine and Pharmacogenomics represent an evolving public health and clinical approach that tailors medical treatment to an individual’s genetic makeup, lifestyle, and environmental factors. Personalized medicine moves away from the traditional “one-size-fits-all” model by using genetic and molecular information to guide prevention, diagnosis, and treatment decisions. Pharmacogenomics, a key component of personalized medicine, studies how genetic variations influence individual responses to medications, including drug effectiveness and risk of adverse reactions. In public health, these approaches have the potential to improve treatment outcomes, enhance patient safety, and reduce healthcare costs by minimizing trial-and-error prescribing. They are especially valuable in managing chronic diseases, cancer therapy, and mental health treatment. Public health challenges include ensuring equitable access, ethical use of genetic data, data privacy, and integration into health systems. When responsibly implemented, personalized medicine and pharmacogenomics support more precise, effective, and patient-centered healthcare.